The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation.
Saved in:
| Title: | The European Clinical, Molecular, and Pathological (ECMP) Criteria and the 2007/2008 Revisions of the World Health Organization for the Diagnosis, Classification, and Staging of Prefibrotic Myeloproliferative Neoplasms Carrying the JAK2V617F Mutation. |
|---|---|
| Alternate Title: | JAK2V617F Mutasyonu Bulunan Prefibrotik Myeloproliferatif Neoplazmların Tanı, Sınıflandırma ve Evrelendirmesinde Dünya Sağlık Örgütü Kriterlerinin 2007/2008 Gözden Geçirilmesi ve Avrupa Klinik, Moleküler ve Patolojik (ECMP) Kriterleri. |
| Authors: | Michiels, Jan Jacques1,2 goodheartcenter@upcmail.nl, Kate, Fibo Ten3, Lam, King H.3, Schroyens, Wilfried1, Berneman, Zwi1, De Raeve, Hendrik4 |
| Source: | Turkish Journal of Hematology. 2014, Vol. 31 Issue 3, p239-254. 16p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
